CD8A and neoplasm: Adoptive transfer of CD8+ T cells derived from PMEL TCR transgenic mice into B16 melanoma-bearing C57BL/6 J mice (Fig. 1E) revealed that ARS2KO CD8+ T cells were unable to control tumor growth as well as ARS2f/f control cells (Fig. 1F).